José Carlos Bouso1, Eduardo José Pedrero-Pérez2, Sam Gandy3, Miguel Ángel Alcázar-Córcoles4. 1. ICEERS Foundation (International Center for Ethnobotanical Education, Research and Services), Spain. jcbouso@iceers.org. 2. Departamento de Evaluación y Calidad, Instituto de Adicciones, Madrid Salud, Ayuntamiento de Madrid, Spain. 3. The College of Life Sciences and Medicine, University of Aberdeen, UK. 4. Departamento de Psicología Biológica y de la Salud. Facultad de Psicología, Universidad Autónoma de Madrid, Spain.
Abstract
OBJECTIVE: In the present study we explored the psychometric properties of three widely used questionnaires to assess the subjective effects of hallucinogens: the Hallucinogen Rating Scale (HRS), the Mystical Experience Questionnaire (MEQ), and the Addiction Research Center Inventory (ARCI). METHODS: These three questionnaires were administered to a sample of 158 subjects (100 men) after taking ayahuasca, a hallucinogen whose main active component is N,N-dimethyltryptamine (DMT). A confirmatory factorial study was conducted to check the adjustment of previous data obtained via theoretical proposals. When this was not possible, we used an exploratory factor analysis without restrictions, based on tetrachoric and polychoric matrices and correlations. RESULTS: Our results sparsely match the theoretical proposals of the authors, perhaps because previous studies have not always employed psychometric methods appropriate to the data obtained. However, these data should be considered preliminary, pending larger samples to confirm or reject the proposed structures obtained. CONCLUSIONS: It is crucial that instruments of sufficiently precise measurement are utilized to make sense of the information obtained in the study of the subjective effects of psychedelic drugs.
OBJECTIVE: In the present study we explored the psychometric properties of three widely used questionnaires to assess the subjective effects of hallucinogens: the Hallucinogen Rating Scale (HRS), the Mystical Experience Questionnaire (MEQ), and the Addiction Research Center Inventory (ARCI). METHODS: These three questionnaires were administered to a sample of 158 subjects (100 men) after taking ayahuasca, a hallucinogen whose main active component is N,N-dimethyltryptamine (DMT). A confirmatory factorial study was conducted to check the adjustment of previous data obtained via theoretical proposals. When this was not possible, we used an exploratory factor analysis without restrictions, based on tetrachoric and polychoric matrices and correlations. RESULTS: Our results sparsely match the theoretical proposals of the authors, perhaps because previous studies have not always employed psychometric methods appropriate to the data obtained. However, these data should be considered preliminary, pending larger samples to confirm or reject the proposed structures obtained. CONCLUSIONS: It is crucial that instruments of sufficiently precise measurement are utilized to make sense of the information obtained in the study of the subjective effects of psychedelic drugs.
Authors: P E Vlisides; T Bel-Bahar; A Nelson; K Chilton; E Smith; E Janke; V Tarnal; P Picton; R E Harris; G A Mashour Journal: Br J Anaesth Date: 2018-04-13 Impact factor: 9.166
Authors: Esther Papaseit; Magí Farré; Clara Pérez-Mañá; Marta Torrens; Mireia Ventura; Mitona Pujadas; Rafael de la Torre; Débora González Journal: Front Pharmacol Date: 2018-03-13 Impact factor: 5.810
Authors: Alan K Davis; Frederick S Barrett; Sara So; Natalie Gukasyan; Thomas C Swift; Roland R Griffiths Journal: J Psychopharmacol Date: 2021-01-09 Impact factor: 4.153
Authors: Alexandre Augusto de Deus Pontual; Luís Fernando Tófoli; Carlos Fernando Collares; Johannes G Ramaekers; Clarissa Mendonça Corradi-Webster Journal: Front Psychol Date: 2021-06-23